$GTHX

G1 Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$12.82 ▼-0.311%

Last Close

VOLUME

662,837

DAY RANGE

12.555 - 13.225

52 WEEK

3.84 - 16.65

Key Metrics

Market Cap

558.27 M

Beta

1.54

Avg. Volume

1.22 M

Shares Outstanding

42.75 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-02

Next Dividend Date

Company Information

G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company's first commercial product, COSELA™ (trilaciclib). G1 has a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including colorectal, breast, lung, and bladder cancers. G1 Therapeutics is based in Research Triangle Park, N.C.

CEO: Mark Velleca

Website:

HQ: 700 Park Offices Drive Research Triangle Park, 27709 North Carolina

Related News